Navigation Links
Anesiva Announces Hiring of Sales Force for FDA-Approved Product Zingo(TM)
Date:1/30/2008

tions.

Anesiva's 15 Regional Account Managers (RAMs) also have a significant amount of tenure and previous success driving formulary additions and uptake in the hospital market. On average, they have 14 years of selling experience, 9 in the hospital arena. The RAMs are located in geographic areas in the United States that have significant concentrations of pediatric hospitals. These institutions perform the majority of the 18 million annual peripheral venous access procedures in children ages three to 18. The RAMs have completed training and are now deployed into their territories.

About Zingo

Zingo provides topical, local analgesia to reduce the pain associated with peripheral IV insertions or blood draws, and is FDA-approved for use in children three to 18 years of age. Zingo is an easy-to-administer, single-use, needle-free system containing 0.5 mg sterile lidocaine powder. It provides rapid onset of action, allowing intravenous line placement or venipuncture to begin one to three minutes after administration.

In two pivotal, multicenter, randomized, double-blind, placebo-controlled clinical studies, a total of 1,114 pediatric patients in the U.S., Zingo demonstrated a statistically significant reduction in procedural pain compared to placebo. In the clinical trials, the most common adverse events were redness (erythema), red dots (petechiae) and swelling (edema) at the site of administration.

About Anesiva and its Diverse Pipeline of Pain Products

Anesiva, Inc. is a late-stage biopharmaceutical company that seeks to be the leader in the development and commercialization of novel pharmaceutical products for pain management. The company has one FDA-approved product, Zingo(TM), for the reduction of pain associated with peripheral venous access procedures in children ages three to 18. The second product in Anesiva's pipeline, Adlea(TM), has been shown to reduce pain after only a single administration for weeks to months in m
'/>"/>

SOURCE Anesiva, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Anesiva to Unveil Zingo(TM) Commercialization Plans
2. Anesiva to Present at BIO InvestorForum on October 11, 2007
3. Anesiva to Announce Third Quarter 2007 Financial Results and Host Webcast Conference Call on November 1, 2007
4. Anesiva Announces Upcoming Webcasts and Conference Participation
5. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
6. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
7. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
8. HEI, Inc. Announces Sale of RFID Division Assets
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
10. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
11. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2015)... Raleigh, NC (PRWEB) April 18, 2015 ... the risk of developing mesothelioma later in life, but ... ways from mesothelioma that is unrelated to radiation. Surviving ... study on its website. Click here to read ... and Australia compared the cases of 45 patients who ...
(Date:4/18/2015)... April 18, 2015 Aureus Medical ... staffing, including physical therapy jobs, has announced that ... South Carolina Physical Therapy Association Annual Conference to ... Center in Greenville, SC. , The SCAPTA ... exhibits with products and services. , Representatives ...
(Date:4/17/2015)... Bradley, Illinois (PRWEB) April 17, 2015 ... host a Party on the Patio from 2 p.m. ... which is located at 1320 Executive Ct. in Pekin, ... on Medicaid, who need some help to maintain their ... steel drums, and tropical treats will be served during ...
(Date:4/17/2015)... Florida Hospital Wesley Chapel, Florida Hospital at ... were all selected as Top Workplaces in Tampa Bay. ... is ranked number one for large businesses according to ... in partnership with an independent research firm. Florida Hospital ... opened in October of 2012 with a vision of ...
(Date:4/17/2015)... April 17, 2015 Representatives Jim Himes ... and Treatment Act HR 1849 in congress on April ... and treatment for patients with the genetic disease. ... past, would be the first to create a federally ... treatment of hereditary hemorrhagic telangiectasia. This would effectively prevent ...
Breaking Medicine News(10 mins):Health News:New Study Examines Relationship Between Radiation for Hematologic Cancers and Development of Mesothelioma, According to Surviving Mesothelioma 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the South Carolina Physical Therapy Association Annual Conference 2Health News:John Evans Supportive Living Community Prepares for Party on the Patio 2Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 2Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 3Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 4Health News:House Representatives Introduce Bill to Fight Genetic Disease 2
... 2010) High doses of antioxidant nutritional supplements, such ... cells, which may predispose supplement-takers to developing cancer, according to ... The study, led by Eduardo Marbn, M.D., Ph.D., director ... the medical journal Stem Cells . The study ...
... find early stage cancers and precancerous growths than current ... -- Noninvasive stool DNA testing can detect two types ... in colon cancer prevention, say two new studies. , ... testing has higher detection rates for curable stage colorectal ...
... readmissions, study finds , TUESDAY, May 4 (HealthDay News) -- ... heart failure patient discharged from the hospital reduces the chance ... but that preventive measure is more often ignored than observed, ... 30,000 hospital patients covered by Medicare found that fewer than ...
... CINCINNATIThe popular diabetes medication metformin works in different fashion ... could lead to wider use of the drugparticularly in ... like tuberous sclerosis and lymphangioleiomyomatosis (LAM). The ... scientific director of UC,s Metabolic Diseases Institute, are published ...
... many times have you, after a particularly hard day, reached ... people, but for those trying to lose weight, it can ... programs never even address it. They focus on choosing ... key question: how can people who have eaten to cope ...
... ... cleaning machine that combines high impact cleaning efficiency with extended operating life, reduced life cycle ... can be completely stripped and rebuilt for maintenance ON-SITE in less than 15 minutes. ... (PRWEB) May 4, 2010 -- ...
Cached Medicine News:Health News:High doses of antioxidant supplements induce stem cell genetic abnormalities 2Health News:New Test for Colon Cancer Under Development 2Health News:Hospitals Falling Short on Heart Patients' Follow-Up Care 2Health News:Popular diabetes drug works differently than thought 2Health News:Managing the emotions behind eating 2Health News:BETE Fog Nozzle Announces HydroWhirl™ Orbitor – Clean-In-Place Rotating Tank Cleaning Machine with High Impact Cleaning for Extended Operating Life 2
(Date:4/17/2015)... April 17, 2015   IBA Molecular, a ... announced today that it has signed a definitive agreement ... Inc. (IBAM NA), to Illinois Health and Science (IHS). Under ... an independent company headquartered in Dulles, Virginia ... advantage of new product and footprint synergies. IBA Molecular ...
(Date:4/17/2015)... 17, 2015 Bionomics Limited (ASX:BNO, ADR:BMICY), a ... innovative therapeutics for the treatment of cancer and diseases ... of data from three of its most advanced oncology ... (AACR) 106 th Annual Meeting being held from ... USA. The presentation on the ...
(Date:4/16/2015)... April 16, 2015 A drug commonly taken to ... people with multiple sclerosis (MS), according to a study released ... Neurology,s 67th Annual Meeting in Washington, DC ... half of people with MS experience at some point in ... the nerve carrying vision from the eye to the brain ...
Breaking Medicine Technology:Health Care System to Acquire IBA Molecular North America 2Health Care System to Acquire IBA Molecular North America 3Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 2Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 3Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 4Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 5Epilepsy Drug May Preserve Eyesight for People with MS 2
... CareFusion will showcase its full portfolio of ... American Society for Health-System Pharmacists (ASHP) Midyear Clinical Meeting ... (Logo: http://photos.prnewswire.com/prnh/20100706/CAREFUSIONLOGO ) "The ... than ever, technology solutions must help increase safety and ...
... 5, 2011 OrbusNeich today announced that data published in ... Genous Stent is safe when accompanied by only 10 days ... trial involving 49 patients treated with Genous, no patient had ... cardiac death, myocardial infarction or angiographic evidence of stent thrombosis ...
Cached Medicine Technology:CareFusion Showcases Medication Management Technologies at American Society for Health-System Pharmacists Conference 2CareFusion Showcases Medication Management Technologies at American Society for Health-System Pharmacists Conference 3Data Published in EuroIntervention Indicate that OrbusNeich's Genous™ Stent Is Safe with Very Short-Term Dual Antiplatelet Therapy 2Data Published in EuroIntervention Indicate that OrbusNeich's Genous™ Stent Is Safe with Very Short-Term Dual Antiplatelet Therapy 3
Illuminated Phoroptor Refracting Instrument. Illumination is provided by a cool-running, energy efficient LEDs (Light Emitting Diodes) that light only what you need to see without affecting the darke...
Double Maddox...
Maddox Rod, short handle (12cm)...
... The Snellen chart remains to most ... range of different optotypes can be ... sheridan-gardner, landolt Cs, tumbling Es and ... column can be shown and a ...
Medicine Products: